Acetazolamide Capsule
Product Images NDC 70710-1591

2 FDA label images from Zydus Pharmaceuticals (usa) Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Acetazolamide (NDC 70710-1591). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals (usa) Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (5d08e0ae B2e8 473f 88cd 917a09ccca7e 01)

Figure (5d08e0ae B2e8 473f 88cd 917a09ccca7e 01)
Chemical structure of acetazolamide showing a heterocyclic ring containing nitrogen, sulfur, and oxygen atoms with attached functional groups including nitro and acetamido groups.*
FDA Label Image

Figure (5d08e0ae B2e8 473f 88cd 917a09ccca7e 02)

Figure (5d08e0ae B2e8 473f 88cd 917a09ccca7e 02)
Label for Acetazolamide Extended-Release Capsules, USP 500 mg, in a package of 100 capsules. The label notes the product is Rx only and includes storage instructions, manufacturer as Zydus Lifesciences Ltd. (India), and distributor Zydus Pharmaceuticals (USA) Inc. (NJ). The label also states the capsules are child-resistant and should be dispensed in a tight container.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.